We report the results of a pilot study conducted to compare the efficacy of oral prostaglandin E2 versus intravenous oxytocin in inducing labour after lower amniotomy in 20 primigravid patients at term. The results suggest no signiflcant differences in the performance of each group for the induction to delivery interval, the mode of delivery, the Apgar score at five minutes or for third stage abnormalities. However, the use of oral PGE2 allows the patient unrestricted mobility and avoids the discomfort of IV infusions.
INTRODUCTION
The secret of successful induction of labour lies in replicating as accurately as possible the physiological processes of spontaneous labour. In the presence of a favourable cervix, a small dose of prostaglandin E2 (PGE2) is often enough to induce a labour very similar to spontaneous labour. This method of induction is also associated with a decrease in postpartum haemorrhage and neonatal jaundice.' The timing of amniotomy is crucial. If performed too early, before the cervix is ripe, it may lead to complications for both mother and fetus. If left too late, we may lose the advantage of its uterine sensitising influence and its augmentatory effect. Women are requesting less interference with labour and, in particular, as little restriction of mobility as possible during its early stages. A combination of oral PGE2and ajudiciously timed amniotomy for induction may allow such mobility and may offer a non-invasive alternative to intravenous oxytocin.
PATIENTS AND METHODS
Ethical committee approval of the protocol was obtained and informed written consent obtained from all patients. Twenty patients were recruited. Group 2 PGE2 (Prostin oral tablets, Upjohn) was administered as an initial dose of 0.5 mg tablet, followed one hour later by 1 mg tablet, and one hour later of 1.5 mg tablet, if the patient is not in established labour. Ifafter three doses the response was poor the options were either to give another 1.5 mg oral dose or to commence intravenous Syntocinon infusion according to the regime prescribed above.
ASSESSMENT
The Bishop score was assessed on entry to the study at the time of low amniotomy (Table I) . Cervical dilatation was measured at least every two hours. The frequency, strength and duration of uterine contractions were recorded by the attending midwife, and the time required from commencement of treatment till labour was established (as defined by regular uterine contractions occurring once every three minutes and lasting for at least 40 seconds). Apgar scores at one and five minutes and the condition of the baby on transfer from the labour ward were assessed. All maternal and fetal adverse events were carefully documented. The attending doctor and midwife were asked for their subjective assessment and the mother was questioned as to the acceptability of the treatment she had received.
The interval between amniotomy and delivery (Table II) was greater in the oral PGE2 group, 9.8 hrs, compared with 7.5 hrs for women receiving oxytocin, although these differences were not statistically significant. 
